Population Pharmacokinetics of Trimethoprim-Sulfamethoxazole in Infants and Children
Julie Autmizguine, Daniel González(University of North Carolina at Chapel Hill), Brenda B. Poindexter(Cincinnati Children's Hospital Medical Center), Samantha Dallefeld(Cleveland Clinic), Michael Cohen‐Wolkowiez(Duke University), Barrie Harper(Clinical Research Institute), Andrew Lewandowski(Emmes (United States)), Chiara Melloni, Susan R. Mendley(University of Maryland, Baltimore), Amira Al‐Uzri(Oregon Health & Science University), Christoph P. Hornik(Duke University), Andrew M. Atz(Medical University of South Carolina), Janice E. Sullivan(University of Louisville), Jeff Mitchell(Emmes (United States)), Ram Yogev(Northwestern University)
Cited by 29
Related Papers
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
|The Lancet|2018|1.8k
The Diagnosis of Bronchopulmonary Dysplasia in Very Preterm Infants. An Evidence-based Approach
|American Journal of Respiratory and Critical Care Medicine|2019|1.2k
Lymphocyte subsets in healthy children from birth through 18 years of age
|Journal of Allergy and Clinical Immunology|2003|828